If I know where the company is going then the stoc
Post# of 11802
I personally think the company, although constrained by resources, has a great plan consisting of alternative brand products, new generation products, and low end products for the uninsured. Anyone who tells you otherwise based on their "experience" is not the person they sat they are and should not be believed. It is plain as the nose on your face, DECN is being positioned for acquisition or if the small shareholders continue to make bigger fools of themselves by calling the authorities and/or potential partners and trashing the character of Mr. Berman, then it will become a strategic partnership, which is a little less. This is exactly what happens to small medical device companies on the precipice of great success.
One other thing. When the license(s) are signed, or the buyout talk starts, the interested parties are not going to consider a purchase of the company because of what is written on message boards by penny stock traders, they are going to buy or license or strategic partner with the person who created all of this, no matter how much stock traders, angry posters, and people who are not who they say they are write.
Just my opinion.
And if after the 3Q 2019 Quarterly you do not know where the company is going, then I suggest you call the company with your questions.